Therapeutic Hypothermia Is Promising Strategy To Minimize Tissue Damage

Main Category: Neurology / Neuroscience
Also Included In: Biology / Biochemistry
Article Date: 21 Mar 2009 - 1:00 PDT

email to a friend   printer friendly   view / write opinions

Recognition of the benefits of cooling strategies to protect the brain and spinal cord after traumatic injury has led to a wealth of cutting edge research, prime examples of which are featured in a special hypothermia issue of Journal of Neurotrauma, a peer-reviewed journal published by Mary Ann Liebert, Inc. The issue will be available free online at http://www.liebertpub.com/neu

The issue includes a series of original articles presenting experimental and clinical evidence to support the use of modest hypothermia in specific conditions. These reports emanated from presentations at the 2nd International Brain Hypothermia Symposium and were selected for publication in the Journal by Guest Editors W. Dalton Dietrich, PhD, and M. Ross Bullock, MD, PhD, both from the University of Miami Miller School of Medicine and Patrick M. Kochanek, MD, from the University of Pittsburgh.

In his Introduction, Dr. Dietrich points out that many factors determine whether hypothermic therapy will be beneficial, including "how early hypothermic therapy is initiated after the insult, the duration of the hypothermic period, the degree of hypothermia, as well as the rewarming protocol. Thus, it is important that basic research studies are continuing in clinical relevant animal models to address these important questions."

The issue explores several aspects of hypothermia, including studies in animal models, its use in the operating room, and its role in the treatment of cardiac arrest, stroke and subarachnoid hemorrhage, traumatic brain (TBI) and spinal cord injury, and pediatric TBI and asphyxia.

Mackensen et al. focus on "Perioperative Hypothermia: Use and Therapeutic Implications," and Kim et al. describe "The Use of Pre-Hospital Mild Hypothermia After Resuscitation from Out-of-Hospital Cardiac Arrest." Kochanek et al. collaborate on two articles on therapeutic hypothermia in pediatric populations, one describing the Safar Vision, and the other focusing on applications in pediatric cardiac arrest. Shankaran presents "Neonatal Encephalopathy: Treatment with Hypothermia," and Bullock et al. provides an overview of "Current and Future Role of Therapeutic Hypothermia."

Notes:

The issue is dedicated to Hubert L. Rosomoff, MD, DMedSc, a world-renowned neurological surgeon and researcher who was a pioneer in the treatment of chronic pain and the use of hypothermia for intracranial vascular surgery.

Journal of Neurotrauma is an authoritative peer-reviewed journal published monthly in print and online that focuses on the latest advances in the clinical and laboratory investigation of traumatic brain and spinal cord injury. Emphasis is on the basic pathobiology of injury to the nervous system, and the articles and reviews evaluate preclinical and clinical trials targeted at improving the early management and long-term care and recovery of patients with traumatic brain injury. Journal of Neurotrauma is the official journal of the National Neurotrauma Society and the International Neurotrauma Society.

Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Tissue Engineering and Surgical Infections. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide.

Source: Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News